Absci (NASDAQ: ABSI) shares business update at J.P. Morgan conference

Rhea-AI Filing Summary

Absci Corporation reported that it will present a business update at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The company has prepared a slide presentation for this event and made it part of its official disclosures.

The slides from Absci's conference presentation are filed as Exhibit 99.1 and are also available on the investor relations section of its website under “Events and Presentations.” This gives investors and analysts access to the same materials being shown at the healthcare conference.

0001672688false00016726882026-01-142026-01-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 14, 2026

ABSCI CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

001-40646

85-3383487

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

18105 SE Mill Plain Blvd

Vancouver, WA 98683

(Address of principal executive offices, including zip code)

(360) 949-1041

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.0001 par value per share			ABSI			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 8.01 Other Events

On January 14, 2026, Absci Corporation (the "Company") will present a business update at the 44th Annual J.P. Morgan Healthcare Conference. A copy of the slides from the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The presentation is available in the “Events and Presentations” section of the Company’s investor relations website at investors.absci.com.

Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Slides from Absci Corporation's presentation filed on January 14, 2026

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Absci Corporation
Date: January 14, 2026			By:			/s/ Sean McClain
						Sean McClain
						Founder & CEO